PuSH - Publication Server of Helmholtz Zentrum München

141 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
81.
Segrè, A.V.* ; Wei, N.* & DIAGRAM Consortium (Florez, J.C* ; Klopp, N. ; Illig, T. ; Müller-Nurasyid, M. ; Peters, A.): Pathways targeted by antidiabetes drugs are enriched for multiple genes associated with type 2 diabetes risk. Diabetes 64, 1470-1483 (2015)
82.
Sweetwyne, M.T.* et al.: Notch1 and Notch2 in podocytes play differential roles during diabetic nephropathy development. Diabetes 64, 4099-4111 (2015)
83.
Törn, C.* et al.: Role of Type 1 diabetes associated SNPs on risk of autoantibody positivity in the TEDDY study. Diabetes 64, 1818-1829 (2015)
84.
Wiedemann, T. ; Bielohuby, M.* ; Müller, T.D. ; Bidlingmaier, M.* & Pellegata, N.S.: Obesity in MENX rats is accompanied by high circulating levels of ghrelin and improved insulin sensitivity. Diabetes 65, 406-420 (2015)
85.
Williams, A.J.* et al.: Detection of antibodies directed to the N-terminal region of GAD is dependent on assay format and contributes to differences in the specificity of GAD autoantibody assays for type 1 diabetes. Diabetes 64, 3239-3246 (2015)
86.
Williams, A.J.* et al.: Reactivity to N-terminally truncated GAD65(96-585) identifies GAD autoantibodies that are more closely associated with diabetes progression in relatives of patients with type 1 diabetes. Diabetes 64, 3247-3252 (2015)
87.
Clemmensen, C. et al.: GLP-1/glucagon co-agonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet. Diabetes 63, 1422-1427 (2014)
88.
Endesfelder, D. et al.: Compromised gut microbiota networks in children with anti-islet cell autoimmunity. Diabetes 63, 2006-2014 (2014)
89.
Ferreira, R.C.* et al.: A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk of type 1 diabetes. Diabetes 63, 2538-2550 (2014)
90.
Habegger, K.M.* et al.: GLP-1R responsiveness predicts individual gastric bypass efficacy on glucose tolerance in rats. Diabetes 63, 505-513 (2014)
91.
Heni, M. et al.: Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men. Diabetes 63, 4083-4088 (2014)
92.
Heppner, K.M.* et al.: Both acyl and des-acyl ghrelin regulate adiposity and glucose metabolism via CNS ghrelin receptors. Diabetes 63, 122-131 (2014)
93.
Herder, C.* et al.: Genetic determinants of circulating interleukin-1 receptor antagonist levels and their association with glycemic traits. Diabetes 63, 4343-4359 (2014)
94.
Keildson, S.* et al.: Expression of phosphofructokinase in skeletal muscle is influenced by genetic variation and associated with insulin sensitivity. Diabetes 63, 1154-1165 (2014)
95.
Tong, J.* et al.: Acute administration of unacylated ghrelin has no effect on basal or stimulated insulin secretion in healthy humans. Diabetes 63, 2309-2319 (2014)
96.
Dimas, A.S.* et al.: Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 63, 2158-2171 (2013)
97.
Ferrannini, E.* et al.: Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes 62, 1730-1737 (2013)
98.
Floegel, A.* et al.: Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62, 639-648 (2013)
99.
Habegger, K.M.* et al.: Fibroblast growth factor 21 mediates specific glucagon actions. Diabetes 62, 1453-1463 (2013)
100.
Habegger, K.M.* et al.: GLP-1R agonism enhances adjustable gastric banding in diet-induced obese rats. Diabetes 62, 3261-3267 (2013)